Skip to main content
. 2021 Aug 31;42(11):1399–1421. doi: 10.1002/humu.24271

Table 1.

GATA2 germline variants reported in families or individuals displaying one or more GATA2 deficiency syndrome (G2DS) phenotypes

Number individuals Familial (F)/de novo (D) GATA2 protein (NP_116027.2) GATA2 cDNA (NM_032638.5) Mutation effect ACMG/AMP classification (curated) ACMG/AMP criteria Overall Phenotype Chromosomal Abnormalities
1 N/A p.(Glu6Alafs*178) c.17_18del FS Pathogenic PVS1, PS4_Supporting, PM2 M/A −7
1 F p.(Gln20*) c.58C>T NS Pathogenic PVS1, PS4_Supporting, PM2 T‐ALL, HA, ID 45,XX,dic(21;22)(p11.2;p11.2)
7 F

p.(Gly28Alafs*52) (in cis p.(His26Pro))

c.77A>C/c.83delG FS Pathogenic PVS1, PS4, PM2, PP1_Moderate M/A, ID, L, HA −7
3 F p.(Glu44*) c.130G>T NS Pathogenic PVS1, PS4_Moderate, PM2 L, HA, ID
1 N/A p.(Ser54*) c.161C>A NS Pathogenic PVS1, PS4_Supporting, PM2 M/A −7
1 F

p.(Tyr59*) (in cis p.?)

c.177C>G (in cis c.[140T>G;142T>C;145T>C])

NS Pathogenic PVS1, PS4_Supporting, PM2 M/A, ID +8
1 D p.(Arg69Leufs*115) c.206_208delGCGinsT FS Pathogenic PVS1, PS2, PS4_Supporting, PM2 M/A
1 N/A p.(Val70Leufs*114) c.207_208delCG FS Pathogenic PVS1, PS4_Supporting, PM2 M/A der(1;7) add
1 D p.? c.222_229+6del14ins21 INDEL Pathogenic PVS1, PS2, PS4_Supporting, PM2 M/A +8
2 F p.? c.229+13_229+14insGCCins203_229+13 INDEL Likely Pathogenic PS4_Moderate, PM2, PP3 M/A, ID +8
3 F p.(Arg78Profs*107) c.232dup [c.230‐1_230insC] FS Pathogenic PVS1, PS4_ Moderate, PM2 M/A, L, HA −7
1 N/A p.(Gly82Argfs*103)[G81fs*] c.243delinsGC FS Pathogenic PVS1, PS4_Supporting, PM2 M/A, ID, HA NK
1 N/A p.(Arg86Profs*98) [C85fs*] c.257_258del FS Pathogenic PVS1, PS4_Supporting, PM2 M/A, ID −7
1 N/A p.(Arg86Alafs*33) c.256del FS Pathogenic PVS1, PS4_Supporting, PM2 ID, M/A, HA
1 N/A p.(Gly101Alafs*18) [G101Afs*16] c.302del FS Pathogenic PVS1, PS4_Supporting, PM2 M/A, CMML, ID, HA del(11)(q13q23), −7, +8
3 N/A p.(Ala103Glnfs*16) c.303del FS Pathogenic PVS1, PS4_ Moderate, PM2 M/A

−7,

der(1;7)(q10;p10),

der(1;7) add

1 N/A p.(Ala103Glnfs*16) c.306del FS Pathogenic PVS1, PS4_Supporting, PM2 M/A −7, add
5 F p.(Leu105Profs*15) c.312_313dup FS Pathogenic PVS1, PS4, PM2 M/A, ID, L, HA ‐7
1 N/A p.(Ser106Cysfs*78) c.317_318del FS Pathogenic PVS1, PS4_Supporting, PM2 ID NK
2 F p.(Ala107Cysfs*78) [S106fs] c.318dup [c.318_319insT] FS Pathogenic PVS1, PS4_ Moderate, PM2 ID, L
15 F p.(Thr117=) c.351C>G SPL Pathogenic PS3_Very Strong, PS4, PM2, PP1_Strong, PP3 M/A, ID, L, HA, NS

−7,

+8,

Chr1 translocation

1 N/A p.(Val118Glyfs*100) [V618fs] c.353del FS Pathogenic PVS1, PS4_Supporting, PM2 M/A −7
1 N/A p.(Gly136Argfs*49) c.404dup FS Pathogenic PVS1, PS4_Supporting, PM2 M/A, ID
1 N/A p.(Ser139Cysfs*78) c.414_417del FS Pathogenic PVS1, PS4_Supporting, PM2 ID, M/A, HA, L
1 N/A p.(Ser139Cysfs*45) c.416_417del FS Pathogenic PVS1, PS4_Supporting, PM2 M/A −7
1 N/A p.(Val140Cysfs*45) [V140Cfs*44] c.417dup FS Pathogenic PVS1, PS4_Supporting, PM2 M/A, ID, HA NK
2 F p.(Tyr141*) c.423C>A NS Pathogenic PVS1, PS4_ Moderate, PM2 M/A, ID −7
1 F p.(Gly146Valfs*72) c.437del FS Pathogenic PVS1, PS4_Supporting, PM2 M/A, ID NK
1 N/A p.(Glu180*) c.538G>T NS Pathogenic PVS1, PS4_Supporting, PM2 M/A, ID NK
1 N/A p.(Thr188Hisfs*14) c.561dup FS Pathogenic PVS1, PS4_Supporting, PM2 M/A NK
1 D p.(Ala194Serfs*8) c.579dup FS Pathogenic PVS1, PS2, PS4_Supporting, PM2 L, M/A −7
1 N/A p.(Ala198Glyfs*20) c.593del FS Pathogenic PVS1, PS4_Supporting, PM2 HA, ID
1 F p.(Gly199Leufs*22) c.586_593dup FS Pathogenic PVS1, PS4_Supporting, PM2 M/A, ID, HA −9q
5 F p.(Gly200Valfs*18) [G199fs*]

c.599del

[c.594delG]

FS Pathogenic PVS1, PS4, PM2 M/A, ID, L −7
11 F/D p.(Ser201*) [G200fs] c.599dup [c.599_600insG] NS Pathogenic PVS1, PS4, PM2 M/A, ID, HA, L +8, −7
1 N/A p.(Arg204*) c.610C>T NS Pathogenic PVS1, PS4_Supporting, PM2 M/A, ID, HA 46,XX,der(9)t(1;9)(q12;q12), r(9)(q12q?34)[15]/46,XX [9]
1 N/A p.(Val211Argfs*72) c.627_630dup FS Pathogenic PVS1, PS4_Supporting, PM2 M/A −7
1 N/A p.(Glu224*) c.670G>T NS Pathogenic PVS1, PS4_Supporting, PM2 M/A, ID, HA NK
1 N/A p.(Leu229Cysfs*5) c.685del FS Pathogenic PVS1, PS4_Supporting, PM2 M/A −7
1 N/A p.(Gly237Alafs*89) [M236Ifs325*] c.710del [c.708delC] FS Pathogenic PVS1, PS4_Supporting, PM2 HA, L, ID
2 N/A p.(Ile246Hisfs*36) [P245fs*] c.735dup [c.735_736insC] FS Pathogenic PVS1, PS4_ Moderate, PM2 ID, M/A, HA
1 F p.(Tyr260Cysfs*25) [Y260fs*24, D259fs*] c.769_778dup FS Pathogenic PVS1, PS4_Supporting, PM2 M/A, ID, HA −7
1 N/A p.(Phe265Glufs*58) c.793_802del FS Pathogenic PVS1, PS4_Supporting, PM2 M/A
3 F p.(Gly268*) c.802G>T NS Pathogenic PVS1, PS4_ Moderate, PM2 M/A, ID, L

−13q

‐7

+8

2 N/A p.(Gly273Thrfs*8) c.817_818del [c.814_815del] FS Pathogenic PVS1, PS4_ Moderate, PM2 M/A

‐7

+8

1 N/A p.(Pro274Thrfs*8) [G273fs*] c.818dupG [c.819insG] FS Pathogenic PVS1, PS4_Supporting, PM2 M/A Other
1 F p.(Ala286Val) c.857C>T MS Likely pathogenic PS3, PS4_Supporting, PM2, PP3 CMML
1 N/A p.(Ser290*) c.869C>A NS Pathogenic PVS1, PS4_Supporting, PM2 HA/ID
3 F p.(Cys298Leufs*86) c.892dup FS Pathogenic PVS1, PS4_ Moderate, PM2 ID, M/A

Chr1‐7 translocation

+8

2 F p.(Trp306Alafs*77) c.915_916del FS Pathogenic PVS1, PS4_ Moderate, PM2 M/A, ID, HA −7
1 N/A p.(Trp306*) c.917G>A NS Pathogenic PVS1, PS4_Supporting, PM2 M/A, HA, L, ID −7
1 N/A p.(Thr311Argfs*71) c.932_937delinsG FS Pathogenic PVS1, PS4_Supporting, PM2 M/A −7
1 F p.(His313Tyr) c.937C>T MS Likely Pathogenic PS4_Supporting, PM1, PM2, PP3 M/A, ID −5, −7, +8, add10, −12, −18, −21
1 F p.(Tyr314Cysfs*66) c.941_951del FS Pathogenic PVS1, PS4_Supporting, PM2 M/A, ID −7
1 N/A p.(Leu315Pro) c.944T>C MS Likely Pathogenic PS4_Supporting, PM1, PM2, PP3 ID
1 N/A p.(Ala318Thrfs*12) c.941_951dup FS Pathogenic PVS1, PS4_Supporting, PM2 M/A, ID, HA −6
1 F p.(Ala318Thr) c.952G>A MS Pathogenic PS3, PS4_Supporting, PM1, PM2, PP3 M/A, ID, HA +1,der(1:7)(q10:p10), +8
1 F p.(Cys319Serfs*5) c.956_962del FS Pathogenic PVS1, PS4_Supporting, PM2 ID, HA
1 N/A p.(His323Glnfs*61) c.968dup FS Pathogenic PVS1, PS4_Supporting, PM2 M/A −7
1 N/A p.(Gln328*) c.982C>T MS Pathogenic PVS1, PS4_Supporting, PM2 M/A, ID dic(1;15)(?;?)
13 F/D p.(Arg330*) c.988C>T NS Pathogenic PVS1, PS4, PM2 M/A, ID, L, HA, JMML

−7,

+8,

+1

1 N/A p.(Leu332Thrfs*53) c.989_992dup [c.992_993insGACC] FS Pathogenic PVS1, PS4_Supporting, PM2 M/A, HA, L −7, +8
1 N/A p.(Leu332Glnfs*60) c.970_994dup FS Pathogenic PVS1, PS4_Supporting, PM2 M/A −7
7 F p.(Arg337*) c.1009C>T NS Pathogenic PVS1, PS4, PM2 M/A, ID, L, HA −7
1 N/A p.? c.1017+1del SPL Pathogenic PVS1, PS4_Supporting, PM2 M/A −7
2 N/A p.? [S340Gfs*99] c.1017+2T>G SPL Pathogenic PVS1, PS4_ Moderate, PM2 M/A, ID, HA −7
1 D p.? [S340Afs*49] c.1017+2T>C SPL Pathogenic PVS1, PS2, PS4_Supporting, PM2 M/A, HA, L, ID
2 F

p.?

INT enhancer (del ETS site)

c.1017+513_1017+540del (c.1017+512del28) REG Likely Pathogenic PS3_Supporting, PS4_ Moderate, PM1, PM2 M/A, ID, HA
30 F

p.?

INT enhancer (ETS site)

c.1017+572C>T REG Pathogenic PS3, PS4, PM1, PM2, PP1_Strong M/A, ID, L, HA, CMML, ALL, B‐ALL

−7

+8

+1

der(Y)t(Y;1)(q11.23;q21)

der(1;7)(q10;p10)

1 N/A p.? c.1018‐11_1027del SPL Pathogenic PVS1, PS4_Supporting, PM2 M/A −7
2 N/A p.? c.1018‐10_1037del SPL Pathogenic PVS1, PS4_ Moderate, PM2 M/A −7
2 N/A p.? [A341Rfs*38] c.1018‐3_1031del SPL Pathogenic PVS1, PS4_ Moderate, PM2 ID, L, HA, HL
2 F p.? c.1018‐2A>G SPL Pathogenic PVS1, PS4_ Moderate, PM2 M/A, L −7
1 N/A p.? c.1018‐2A>T SPL Pathogenic PVS1, PS4_Supporting, PM2 M/A −7
2 N/A p.? [S340‐N381del] c.1018‐1G>A DEL Likely Pathogenic PVS1_Strong, PS4_ Moderate, PM2 M/A,HA, ID der(22)t(1;22)(q12;p13)/der(15)t(1;15)(q12;p13)
1 N/A p.? [S340‐N381del] c.1018‐1G>T DEL Likely Pathogenic PVS1_Strong, PS4_Supporting, PM2 HA,ID
2 F p.(Ser340Lysfs*40) c.1018_1028del FS Pathogenic PVS1, PS4_ Moderate, PM2 M/A, ID NK
1 N/A p.(Ser340Trpfs*47) c.1019del FS Pathogenic PVS1, PS4_Supporting, PM2 M/A −7
1 N/A p.(Ala341Aspfs*53) c.1019_1020insCGACTGGGAGGGCAAGGCAG FS Pathogenic PVS1, PS4_Supporting, PM2 M/A, HA, L, ID
1 N/A p.(Ala341Profs*46) c.1021del FS Pathogenic PVS1, PS4_Supporting, PM2 HA, ID, L
1 N/A p.(Ala341Profs*45) c.1021_1024del [c.1019_1022del] FS Pathogenic PVS1, PS4_Supporting, PM2 L, M/A, HL
3 F p.(Ala341Serfs*39) c.1021_1031del FS Pathogenic PVS1, PS4_ Moderate, PM2 M/A, ID −7, +8
1 N/A p.(Ala342Argfs*42) c.1023dup FS Pathogenic PVS1, PS4_Supporting, PM2 M/A, ID NK
2 F p.(Ala342Profs*45) c.1023del FS Pathogenic PVS1, PS4_ Moderate, PM2 ID, L NK
2 N/A p.(Ala342del)l [341delA] c.1024_1026del [c.1021_1023] DEL Pathogenic PVS1, PS4_ Moderate, PM2 M/A −7
1 N/A p.(Arg343Profs*42) [A342Gfs*41] c.1025_1026insGCCG FS Pathogenic PVS1, PS4_Supporting, PM2 ID, HA
2 F p.(Arg344Glnfs*41) c.1023_1026dup FS Pathogenic PVS1, PS4_ Moderate, PM2 M/A, ID, HA −7
3 N/A p.(Arg344Glyfs*43) c.1020_1029dup FS Pathogenic PVS1, PS4_ Moderate, PM2 M/A, ID, L, HA NK
1 D p.(Arg344Lysfs*37) c.1031_1049del FS Pathogenic PVS1, PS2, PS4_Supporting, PM2 M/A NK
1 N/A p.(R344Kfs*40) N/A FS Pathogenic PVS1, PS4_Supporting, PM2 M/A NK
1 N/A p.(Gly346Serfs*40)

c.1035_1036ins

TCTGGCC

FS Pathogenic PVS1, PS4_Supporting, PM2 M/A, ID, HA
1 D p.(Thr347Argfs*38) c.1035_1038dup FS Pathogenic PVS1, PS2, PS4_Supporting, PM2 M/A −7
1 N/A p.(Thr347Argfs*42) c.1023_1038dup (c.1038_1039insCGCCAGAAGAGCCGGC) FS Pathogenic PVS1, PS4_Supporting, PM2 M/A −7
2 F p.(T347fs) 16bp tandem dup FS Pathogenic PVS1, PS4_ Moderate, PM2 ID, HA
1 N/A p.(Cys348Valfs*39) c.1041del FS Pathogenic PVS1, PS4_Supporting, PM2 ID, M/A, HA −7
1 D p.(Cys349Phe) [C348F] c.1046G>T MS Likely Pathogenic PS2, PS4_Supporting, PM1, PM2, PM5, PP3 M/A −7
1 D p.(Cys349Arg) c.1045T>C MS Pathogenic PS2, PS4_Supporting, PM1, PM2, PM5, PP3 M/A, ID

46,XY,der(3)t

dic(1;3)(p11; p25)

1 N/A p.(Cys349Gly) c.1045T>G MS Likely Pathogenic PS4_Supporting, PM1, PM2, PM5, PP3 ID, M/A,L
1 N/A p.(Asn351Ser) c.1052A>G MS Likely Pathogenic PS4_Supporting, PM1, PM2, PP3 M/A −7
1 F p.(Cys352Arg) c.1054T>C MS Likely Pathogenic PS4_Supporting, PM1, PM2, PM5, PP3 M/A
1 N/A p.(Cys352Gly) c.1054T>G MS Likely Pathogenic PS4_Supporting, PM1, PM2, PM5, PP33 M/A −7
1 N/A p.(Cys352Valfs*35) c.1054del FS Pathogenic PVS1, PS4_Supporting, PM2 ID, M/A, HA, L NK
1 N/A p.(Cys352Phe) c.1055G>T MS Likely Pathogenic PS4_Supporting, PM1, PM2, PM5, PP3 M/A der(1;7)(q10;p10),+1
2 F/D p.(Thr354Pro) c.1060A>C MS Pathogenic PS2, PS4_Moderate, PM1, PM2, PM5, PP3 M/A, ID, L, HA NK
53 F p.(Thr354Met) c.1061C>T MS Pathogenic PS3, PS4, PM1, PM2, PM5, PP1_Strong, PP3 M/A, ID, L, HA

−7, +8, +21, −5q, 1q abnormality, isochromosome 17, F100 t(1q:7p)

+8 replaced by monodicentric 6

1 F p.(Thr354Arg) c.1061C>G MS Likely Pathogenic PS4_Supporting, PM1, PM2, PM5, PP3 M/A, ID 46,XX [20]/92,XXXX [2]
2 F p.(Thr358del) [355delT]

c.1065_1067del [c.1063_1065delACA]

DEL Pathogenic PS3, PS4_Moderate, PM2, PM4 M/A

−7

+8

1 N/A p.(Thr358del) c.1072_1074del DEL Pathogenic PS3, PS4_Moderate, PM2, PM4 ID
1 N/A p.(Thr356_Asn365del) c.1066_1095del DEL Likely Pathogenic PS4_Supporting, PM2, PM4_Strong M/A −7
2 N/A p.(Thr357Ala) c.1069A>G MS Likely Pathogenic PS4_ Moderate, PM1, PM2, PM5, PP3 M/A

der(1;7), add

+8

1 N/A p.(Thr357Ile) c.1070C>T MS Likely Pathogenic PS4_Supporting, PM1, PM2, PM5, PP3 M/A, ID NK
1 F

p.(Thr358Asn), p.(Leu359Val)

(in‐cis)

c.1073C>A

c.1075T>G

MS Pathogenic/VUS PS3, PS4_Supporting, PM1, PM2, PP3/PM1, PM2, PM5, PP3, BP2 M/A, HA, ID
1 F p.(Leu359Val) c.1076T>C MS Likely Pathogenic PS4_Supporting, PM1, PM2, PP3 M/A, ID, L

46,XX,del(5)(q2?3q

3?3) [18]/46,XX

3 F p.(Trp360Arg) c.1078T>A MS Likely Pathogenic PS4_Moderate, PM1, PM2, PM5, PP3 ID, L, HA
1 F p.(Trp360Leu) c.1079G>T MS Likely Pathogenic PS4_Supporting, PM1, PM2, PM5, PP3 M/A, HA, ID −7
2 F p.(Arg361Gly) c.1081C>G MS Likely Pathogenic PS4_Moderate, PM1, PM2, PM5, PP3 M/A, ID, L
7 F p.(Arg361Cys) c.1081C>T MS Likely Pathogenic PS4, PM1, PM5, PP3 MA, ID, L, HA −7
1 D p.(Arg361Leu) c.1082G>T MS Pathogenic PS2, PS3, PS4_Supporting, PM1, PM2, PM5, PP3 L, HA, ID
8 F p.(Arg361His) c.1082 G>A MS Pathogenic PS4, PM1, PM2, PM5, PP3 M/A, NS, ID −7, +8
1 N/A

p.(Arg362_Asn365 del) [R361del4]

c.1084_1095del [c.1083_1094del12]

DEL Likely Pathogenic PS4_Supporting, PM2, PM4_Strong M/A, ID, HA −7, +21, +8
17 F/D p.(Arg362*) c.1084C>T NS Pathogenic PVS1, PS4, PM2 M/A, ID, L, HA

−7, add

+8

−20q

2 F p.(Arg362Pro) c.1085G>C MS Likely Pathogenic PS4_ Moderate, PM1, PM2, PP3 M/A, ID, L

−7

+8

1 N/A p.(Asp367Thrfs*20) c.1099del FS Pathogenic PVS1, PS4_Supporting, PM2 M/A, HA, ID
3 F p.(Asp367Glyfs*17) c.1099dup [c.1099insG] FS Pathogenic PVS1, PS4_ Moderate, PM2 M/A, ID, HA NK
1 N/A p.(Pro368Argfs*15) c.1103_1104del FS Pathogenic PVS1, PS4_Supporting, PM2 NS
1 N/A p.(Cys370Trp) c.1110C>G MS Likely Pathogenic PS4_Supporting, PM1, PM2, PP3 M/A −7
4 N/A p.(Asn371Lys) c.1113C>A MS Pathogenic PS1, PS4, PM1, PM2, PP3 MA, L, ID

−7

+8

2 N/A p.(Asn371Lys) c.1113C>G MS Pathogenic PS1, PS4_Moderate, PM1, PM2, PP3 M/A, HA,ID −7, +mar
1 N/A p.(Asn371Lysfs*16) c.1113del FS Pathogenic PVS1, PS4_Supporting, PM2 M/A −7, +8
6 F p.(Ala372Thr) c.1114G>A MS Likely Pathogenic PS4, PM1, PM2, PP3 M/A, ID, L −7, +15, +20 t(11;19), +8
3 F

p.(Cys373_Tyr377del)

[C373del5]

c.1117_1131del [c.1116_1130del15] DEL Likely Pathogenic PS4_ Moderate, PM2, PM4_Strong* M/A, ID −7
1 N/A p.(Cys373Tyr) c.1118G>A MS Likely Pathogenic PS4_Supporting, PM1, PM2, PM5, PP3 M/A, ID, L

+1

−15

1 N/A p.(Cys373Arg) c.1117T>C MS Likely Pathogenic PS3_Supporting, PS4_Supporting, PM1, PM2, PM5, PP3 L, M/A, ID −7
1 N/A

p.(Leu375Val),

p.?

c.1123C>G in‐cis with

355 bp of GATA2 locus (part of last intron & exon) that has been duplicated and inserted into the last exon

MS,

INS

Likely Pathogenic PM1, PM2, PM5, PP3 M/A NK
3 F p.(Leu375Phe) c.1123C>T MS Likely Pathogenic PS4_Moderate, PM1, PM2, PM5, PP3 M/A, ID, L, HA −7, +8, +20
2 D p.(Leu375Profs*12) c.1124del FS Pathogenic PVS1, PS2, PS4_ Moderate, PM2 M/A −7
1 D p.(Tyr376*) c.1128C>G NS Pathogenic PVS1, PS2, PS4_Supporting, PM2 M/A NK
1 N/A p.(Tyr377Asp) c.1129T>G MS Likely Pathogenic PS4_Supporting, PM1, PM2, PP3 ID, HA
1 N/A p.(Lys378*) c.1132A>T NS Pathogenic PVS1, PS4_Supporting, PM2 HA, ID hyperdiploidy (>80 chr), +8
2 F p.(Lys378Asnfs*12) c.1126_1133dup FS Pathogenic PVS1, PS4_ Moderate, PM2 HA, ID, M/A NK
1 N/A p.(Asn381Metfs*6) c.1142del FS Pathogenic PVS1, PS4_Supporting, PM2 M/A, ID NK
1 D

p.? [S340_N381del, V382Gfs*23 or N381_V382ins41]

c.1143+2T>A SPL Pathogenic PVS1, PS2, PS4_Supporting, PM2 M/A, ID, HA +8
3 D p.? [N381fs*20] c.1143+5G>A SPL Likely Pathogenic PS3, PS4_Moderate, PM2, PM6_Supporting ID, M/A
2 N/A p.? c.1143+5G>C SPL Likely Pathogenic PS1_Supporting, PS4_Moderate, PM2, PP3 M/A, ID +8
1 N/A p.? [N381fs*] c.1143+200_1198del DEL Pathogenic PVS1, PS4_Supporting, PM2 HA, ID, L NK
3 F p.(Pro385Gln) c.1154C>A MS Likely Pathogenic PS4_ Moderate, PM1, PM2, PP3 M/A, ID, L, T‐ALL −7
1 N/A p.(Thr387Asn) c.1160C>A MS Likely Pathogenic PS4_Supporting, PM1, PM2, PP3 M/A +8
2 F p.(Met388Val) c.1162A>G MS Likely Pathogenic PS4_ Moderate, PM1, PM2, PM5, PP3 M/A, HA, ID

−7

+8

5 F p.(Met388Thr) c.1163T>C MS Likely Pathogenic PS4, PM1, PM2, PM5, PP3 ID, HA
1 N/A p.(Lys390Glu) c.1168A>G MS Likely Pathogenic PS4_Moderate, PM1, PM2, PP3 M/A der(1;7) add
1 N/A p.(Glu391Glyfs*85) c.1172_1175del FS Pathogenic PVS1, PS4_Supporting, PM2 ID, HA
12 F p.(Arg396Trp) c.1186C>T MS Pathogenic PS4, PM1, PM2, PM5, PP3 M/A, ID, L, HA +8, +mar, −7, −21
24 F/D p.(Arg396Gln) c.1187G>A MS Pathogenic PS2, PS3, PS4, PM1, PM2, PM5, PP1_Moderate, PP3 M/A, ID, L, HA +8, −7, +11, der(1;16), add
3 F p.(Arg396Leu) c.1187G>T MS Likely Pathogenic PS3_Supporting, PS4_ Moderate, PM1, PM2, PM5, PP1_Supporting, PP3 M/A, HA, ID
22 F p.(Arg398Trp) c.1192C>T MS Pathogenic PS3, PS4, PM1, PM2, PM5, PP1_Moderate, PP3 M/A, ID, HA, CMML, JMML, L +1, −7, +8, ‐X
4 F p.(Arg398Gln) c.1193G>A MS Likely Pathogenic PS4, PM1, PM5, PP3 M/A, ID −7, +8
1 N/A p.(Lys406Serfs*77)

c.1200_1216dup [c.1216_1217ins17]

FS Pathogenic PVS1, PS4_Supporting, PM2 M/A −7
1 N/A p.(Phe428Leufs*108) c.1281dup [c.1281_1282insC] FS Pathogenic PVS1, PS4_Supporting, PM2 M/A
1 N/A p.(His442Glnfs*95) c.1322_1325dup FS Likely pathogenic PVS1_Moderate, PS4_Supporting, PM2 M/A
8 F p.(Ser447Arg) c.1339A>C MS Pathogenic PS1, PS4, PM2, PP1_Moderate, PP3 M/A, ID, HA +8
2 N/A p.(Ser447Arg) c.1341C>A MS Likely pathogenic PS1, PS4_Moderate, PM2 M/A −7
1 N/A

Deletion (whole protein)

DEL Pathogenic PVS1, PS4_Supporting, PM2 L, M/A, ID, DF, NS +21
1 N/A

Deletion (whole protein)

DEL Pathogenic PVS1, PS4_Supporting, PM2 M/A, ID, DF, NS, HA
1 N/A

Deletion (whole protein)

DEL Pathogenic PVS1, PS4_Supporting, PM2 HA, ID
1 N/A

Deletion (whole protein)

DEL Pathogenic PVS1, PS4_Supporting, PM2 ID, HA
2 N/A

Deletion (whole protein)

c.1‐?_1443+?del DEL Pathogenic PVS1, PS4_ Moderate, PM2 M/A, ID NK
1 N/A

Deletion (whole protein)

DEL Pathogenic PVS1, PS4_Supporting, PM2 M/A, ID, DF, NS, HA −7
1 N/A

Deletion (whole protein)

DEL Pathogenic PVS1, PS4_Supporting, PM2 M/A, HA, ID, L −7, +8
1 N/A

Deletion (whole protein)

DEL Pathogenic PVS1, PS4_Supporting, PM2 M/A, HA, ID
1 N/A

Deletion (whole protein)

DEL Pathogenic PVS1, PS4_Supporting, PM2 M/A −7
1 N/A del3q21 DEL Pathogenic PVS1, PS4_Supporting, PM2 M/A, ID, NS del3q21, −7
1 N/A Deletion DEL Pathogenic PVS1, PS4_Supporting, PM2 M/A, HA, ID 45,XY,‐7[7]/46,XY,‐7,+mar[10]/46,XY[8]
1 N/A Deletion DEL Pathogenic PVS1, PS4_Supporting, PM2 HA, ID
1 F

Delete ATG start codon

DEL Pathogenic PVS1, PS4_Supporting, PM2 M/A t(2;12)(p21;p13)
3 F p.? (M1del290) c.‐45‐155_871+527del DEL Pathogenic PVS1, PS4_ Moderate, PM2 M/A, ID, L, HA NK
1 N/A p.? DEL Pathogenic PVS1, PS4_Supporting, PM2 M/A, HA
1 F p.? DEL Pathogenic PVS1, PS4_Supporting, PM2 M/A −7
1 F p.? DEL Pathogenic PVS1, PS4_Supporting, PM2 M/A, ID (7q22)x1,(7q31)x1 [260/400]
1 F del ZF2 & C‐terminus c.1018‐? DEL Pathogenic PVS1, PS4_Supporting, PM2 M/A, ID
1 N/A del ZF2 & C‐terminus c.1018‐?_1443+?del DEL Pathogenic PVS1, PS4_Supporting, PM2 ID, M/A

Note: This table summarizes germline GATA2 likely pathogenic/pathogenic variants with full details available in Table S1. All mutations are numbered from the ATG start codon of GATA2 NM_032638.5 and NP_116027.2. Where the original published nomenclature differs, the original published mutation is indicated in square brackets []. For each mutation, the observed phenotypes for each individual were combined to generate the overall phenotype. Overall phenotypes: CMML, chronic myelomonocytic leukemia; DF, dysmorphic features; HA, hematological abnormality; HL, hearing loss; ID, immunodeficiency; JMML, juvenile myelomonocytic leukemia; L, lymphedema; M/A, MDS and/or AML; NS, neurologic symptoms; T‐ALL, T‐cell acute lymphoblastic leukemia. Mutation effect: DEL, large deletion; FS, frameshift; INDEL, small insertion/deletion; MS, missense; NS, nonsense; REG, regulatory; SPL, splice site.